Yuetian Yu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Objective. To investigate the effect of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in serum, bronchoalveolar lavage fluid (BALF), endotracheal aspiration (ETA), and exhaled breath condensate (EBC) samples as early biomarkers for the diagnosis of ventilator-associated pneumonia (VAP) in patients with ischemic stroke. Methods. One(More)
Objective. To investigate whether high-flow nasal cannula (HFNC) oxygen therapy is superior to conventional oxygen therapy for reducing hypoxemia and postoperative pulmonary complications (PPC) in patients with thoracoscopic lobectomy after extubation. Methods. Patients with intermediate to high risk for PPC were enrolled in this study. Subjects were(More)
Objective. To investigate whether prior treatment of atorvastatin reduces the frequency of hospital acquired pneumonia (HAP). Methods. Totally, 492 patients with acute ischemic stroke and Glasgow Coma Scale ≤ 8 were enrolled in this study. Subjects were assigned to prior atorvastatin treatment group (n = 268, PG) and no prior treatment group (n = 224, NG).(More)
In a recent issue of Critical Care, Maria Schroeder et al. [1] reported a prospective observational study involving 85 patients who had positive Aspergillus cultures or had only a positive galactomannan test. They hypothesized that a diagnostic algorithm including the detection of galactomannan in bronchoalveolar lavage fluid (BALF) would increase the(More)
  • 1